Taletrectinib is a targeted therapeutic agent indicated for the treatment of non-small cell lung cancer (NSCLC) positive for ALK/ROS1 gene fusions. It halts the growth of cancer cells by inhibiting abnormal kinase activity.
What is Taletrectinib?
Update: 30 Jan,2026 Source: Haiou Health Views: 127
